Sana Biotechnology, Inc. (SANA) Misses Q1 EPS by 1c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q1 EPS of ($0.17), $0.01 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Matinas BioPharma gets NYSE American compliance notice
• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story